Kamal O.

Kamal O. is the CEO and Co-founder of Nebula Genomics, which has established itself as the largest provider of direct-to-consumer whole genome sequencing globally and was acquired by Prophase (NASDAQ:PRPH). Prior to this role, Kamal served as a Product Manager at Google and as CEO of Patchco, a company developed to create a smaller, safer version of the EpiPen, which received backing from the Y Combinator Fellowship. Kamal's educational background includes an MD-PhD from Stanford University School of Medicine and a Master of Philosophy in Advanced Computer Science from the University of Cambridge.